酒精性肝炎新进展

高斌; Vijay H.Shah

doi:10.3969/j.issn.1001-5256.2019.03.001

酒精性肝炎新进展

DOI: 10.3969/j.issn.1001-5256.2019.03.001

1. 国立卫生研究院酒精滥用与中毒研究所肝病实验室
2. 梅奥诊所消化内科

详细信息

中图分类号: R575.1
计量
- 文章访问数: 1570
- HTML全文浏览量: 14
- PDF下载量: 448
- 被引次数: 0
出版历程
- 出版日期: 2019-03-20

What's new in alcoholic hepatitis

.Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA

摘要

摘要:
酒精性肝炎是酒精性肝病的重要表现形式,通常以酗酒所致的急性肝脏炎症为特征。本文就酒精性肝炎的发病机制、临床特征、诊断、现有治疗方法及未来治疗策略等进行了概括及评述,以帮助肝病医生在临床实践中更好地认识这一类疾病。
- 肝炎,酒精性 /
- 述评
Abstract:
Alcoholic hepatitis is an important type of alcohol-associated liver disease characterized by acute liver inflammation caused by pro-longed heavy alcohol use. In the present article, the pathogenesis, clinical characteristics, diagnosis, current therapies and future treatmentstrategies of alcoholic hepatitis are summarized and reviewed in order to help the hepatologists to better understand this kind of disease in clini-cal practice.
- hepatitis, alcoholic /
- editorial

HTML全文

参考文献(24)

[1] BECKETT AG, LIVINGSTONE AV, HILL KR. Acute alcoholichepatitis[J]. Br Med J, 1961, 2 (5260) :1113-1139.

[2] CRABB DW, BATALLER R, CHALASANI NP, et al. Standarddefinitions and common data elements for clinical trials in pa-tients with alcoholic hepatitis:Recommendation from theNIAAA alcoholic hepatitis consortia[J]. Gastroenterology, 2016, 150 (4) :785-790.

[3] MANDREKAR P, BATALLER R, TSUKAMOTO H, et al. Alco-holic hepatitis:Translational approaches to develop targetedtherapies[J]. Hepatology, 2016, 64 (4) :1343-1355.

[4] GAO B, BATALLER R. Alcoholic liver disease:pathogenesisand new therapeutic targets[J]. Gastroenterology, 2011, 141 (5) :1572-1585.

[5] SEITZ HK, BATALLER R, CORTEZ-PINTO H, et al. Alcoholicliver disease[J]. Nat Rev Dis Primers, 2018, 4 (1) :16.

[6] XU MJ, ZHOU Z, PARKER R, et al. Targeting inflammation forthe treatment of alcoholic liver disease[J]. Pharmacol Ther, 2017, 180:77-89.

[7] CHEN P, MIYAMOTO Y, MAZAGOVA M, et al. Microbiota and al-coholic liver disease[J]. Alcohol Clin Exp Res, 2016, 40 (8) :1791-1792.

[8] DUBUQUOY L, LOUVET A, LASSAILLY G, et al. Progenitorcell expansion and impaired hepatocyte regeneration in ex-planted livers from alcoholic hepatitis[J]. Gut, 2015, 64 (12) :1949-1960.

[9] BERTOLA A, MATHEWS S, KI SH, et al. Mouse model ofchronic and binge ethanol feeding (the NIAAA model) [J].Nat Protoc, 2013, 8 (3) :627-637.

[10] LAZARO R, WU R, LEE S, et al. Osteopontin deficiency doesnot prevent but promotes alcoholic neutrophilic hepatitis inmice[J]. Hepatology, 2015, 61:129-140.

[11] BERTOLA A, PARK O, GAO B. Chronic plus binge ethanolfeeding synergistically induces neutrophil infiltration and liverinjury:A critical role for E-selectin[J]. Hepatology, 2013, 58 (5) :1814-1823.

[12] GAO B, XU MJ, BERTOLA A, et al. Animal models of alcohol-ic liver disease:Pathogenesis and clinical relevance[J].Gene Expr, 2017, 17 (3) :173-186.

[13] KI SH, PARK O, ZHENG M, et al. Interleukin-22 treatment amel-iorates alcoholic liver injury in a murine model of chronic-bingeethanol feeding:Role of signal transducer and activator of tran-scription 3[J]. Hepatology, 2010, 52 (4) :1291-1300.

[14] PETRASEK J, BALA S, CSAK T, et al. IL-1 receptor antagonistameliorates inflammasome-dependent alcoholic steatohepatitisin mice[J]. J Clin Invest, 2012, 122 (10) :3476-3489.

[15] SZABO G. Clinical trial design for alcoholic hepatitis[J]. Se-min Liver Dis, 2017, 37 (4) :332-342.

[16] SINGAL AK, SHAH VH. Therapeutic strategies for the treat-ment of alcoholic hepatitis[J]. Semin Liver Dis, 2016, 36 (1) :56-68.

[17] GAO B, XIANG X. Interleukin-22 from bench to bedside:Apromising drug for epithelial repair[J]. Cell Mol Immunol, 2018.[Epub ahead of print]

[18] SINGH V, KEISHAM A, BHALLA A, et al. Efficacy of granulo-cyte colony-stimulating factor and N-acetylcysteine thera-pies in patients with severe alcoholic hepatitis[J]. Clin Gastro-enterol Hepatol, 2018, 16 (10) :1650-1656. e2.

[19] SINGH V, SHARMA AK, NARASIMHAN RL, et al. Granulocytecolony-stimulating factor in severe alcoholic hepatitis:A ran-domized pilot study[J]. Am J Gastroenterol, 2014, 109 (9) :1417-1423.

[20] MATHURIN P, MORENO C, SAMUEL D, et al. Early livertransplantation for severe alcoholic hepatitis[J]. N Engl JMed, 2011, 365 (19) :1790-1800.

[21] ARTRU F, LOUVET A, MATHURIN P. Liver transplantation forpatients with alcoholic hepatitis[J]. Liver Int, 2017, 37 (3) :337-339.

[22] LEE BP, MEHTA N, PLATT L, et al. Outcomes of early livertransplantation for patients with severe alcoholic hepatitis[J].Gastroenterology, 2018, 155 (2) :422-430. e1.

[23] LEE BP, CHEN PH, HAUGEN C, et al. Three-year results ofa pilot program in early liver transplantation for severe alcoholichepatitis[J]. Ann Surg, 2017, 265 (1) :20-29.

[24] WU T, MORGAN TR, KLEIN AS, et al. Controversies in earlyliver transplantation for severe alcoholic hepatitis[J]. AnnHepatol, 2018, 17 (5) :759-768.

施引文献

资源附件(0)

访问统计